Malignant Peritoneal Neoplasm Not Yet Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03430700Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal CancerTreatment